Immuno-Oncology Program
Boston, MA 02215
Using Immuno-Oncology to Treat Cancer
Our Immuno-Oncology Program is internationally recognized for contributions to the biologic treatment of cancer using cytokines (IL-2,1 FN), targeted immunotherapy (CTLA4 and PD1 antibodies), vaccines and other novel agents. Our Immuno-Oncology Program specialists, including Drs. David McDermott, James Mier and Rupal Bhatt, investigate and use biologic agents, such as cytokines and vaccines, to treat patients with advanced melanoma and kidney cancer.
More About Immuno-Oncology
Immuno-Oncology Clinical Trials
Our program conducts pivotal clinical trials that have led to FDA approval for therapies for metastatic kidney cancer and melanoma (skin cancer).
Prepare for Your Visit
To help you prepare for your first visit to our Cancer Center's Immuno-Oncology Clinic, read these FAQs on what to expect.
Immuno-Oncology Research
We specialize in kidney cancer research, working to find better methods of early detection and treatment for renal cell carcinoma.